Vir Biotechnology, Inc.
VIR
$5.09
-$0.325-6.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.08% | 15.14% | 11.21% | -84.39% | -275.43% |
| Total Depreciation and Amortization | -29.57% | -25.15% | -4.57% | 27.25% | 68.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.67% | 19.47% | 66.89% | 202.48% | -65.14% |
| Change in Net Operating Assets | 106.09% | 72.42% | 29.76% | 12.19% | -159.13% |
| Cash from Operations | 45.56% | 42.69% | 26.60% | -24.58% | -177.21% |
| Capital Expenditure | 57.43% | 66.16% | 80.29% | 83.74% | 71.92% |
| Sale of Property, Plant, and Equipment | 485.37% | -- | 4,268.18% | 8,390.91% | 4,541.67% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 442.00% | 170.30% | 74.12% | 118.92% | 111.92% |
| Cash from Investing | 529.43% | 203.33% | 118.24% | 115.65% | 109.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 2,400.00% | -- | 107.94% | 98.52% | 98.85% |
| Issuance of Common Stock | -13.17% | -41.38% | -37.31% | -45.43% | -40.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 57.36% | 42.51% | -- | -- | -487.00% |
| Cash from Financing | -8.59% | -41.34% | -38.48% | -46.94% | -43.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 128.32% | 109.46% | 59.34% | 55.98% | -9,820.13% |